pharma · Acute Myeloid Leukemia · Relapsed and/or refractory Acute Myeloid Leukemia · KURA
Kura Oncology
Kura Oncology trial registry — 25 ClinicalTrials.gov studies with program phase, status, and indication context.
12730 High Bluff Dr, Suite 400, San Diego, California 92130, US HQ
2014 Founded
313 Employees
Public company Type
KURA · NYSE Ticker
Company details
- Status
- Public
- HQ
- 12730 High Bluff Dr, Suite 400, San Diego, California 92130, US
- Founded
- 2014
- Employees
- 313
- Programs
- 25
- Drugs
- 14
- Patents
- 132
Kura Oncology clinical trials
Registry index of 25 ClinicalTrials.gov studies linked to Kura Oncology programs — each row shows trial ID, program name, phase, status, and indication.
Kura Oncology trial registry — 25 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Kura Oncology.
-
KO-MEN-017 — Phase 3
Clinical update -
KO-MEN-008 — Phase 1
Clinical update -
Ziftomenib, Ziftomenib — Phase 2
Clinical update -
Ziftomenib — Phase 1
Clinical update -
ziftomenib — Phase 1
Clinical update -
Ziftomenib — Phase 1
Clinical update -
Ziftomenib — Phase 2
Clinical update -
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors — Phase 1
Clinical update
Trial registry
-
CTIS ↗ -
CTIS ↗ - 2024-513285-19-00CTIS ↗
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Pancreatic Ductal Adeno Carcinoma, Colorectal Cancer, Non- Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma
-
CTIS ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗